BACKGROUND/OBJECTIVES: Excess mortality after hip fracture is higher in men than in women. The objective was to study whether comorbidity differs in men and women with hip fracture and to what degree differences in comorbidity according to gender may explain the higher excess mortality in men. DESIGN: Population-based matched cohort covering the population aged 50 and older in Norway. SETTING: Specialist healthcare (individuals with hip fracture) and general population (controls). PARTICIPANTS: All individuals with hip fracture aged 50 and older from 2005 to 2008 (n = 32,175) and individuals without hip fracture matched 3:1 to those with hip fracture on gender, age, and county of residence (n = 96,410). MEASUREMENTS: Comorbid diagnoses were recorded during the hospital stay. Relative and absolute excess 1-year mortality in individuals with hip fracture according to gender and Charlson Comorbidity Index (CCI) were investigated using Cox regression and linear regression, respectively. RESULTS: Despite lower age (mean 78.7 vs 81.7), men had higher comorbidity than women. Compared with controls, women (hazard ratio (HR) = 6.5, 95% confidence interval (CI) = 6.2-6.9) and men (HR = 7.8, 95% CI = 7.3-8.3) with a CCI of 2 or greater were more likely to die. Women with a CCI of 2 or greater had an estimated 1-year risk of dying of 44%, and controls had an 11% risk; men with a CCI of 2 or greater had an estimated risk of dying of 53%, and controls had a 12% risk. Men were twice as likely as women to die within 1 year (HR = 2.0, 95% CI = 1.9-2.1). When adjusting for
N orway has one of the highest incidence rates of hip fracture in the world. 1 Older age and female gender are strong risk factors. Men account for 30% of hip fractures. 2 Men and women have excess mortality after hip fracture, 3, 4 but there is evidence to suggest that men who fracture their hip are in worse health. [5] [6] [7] Male gender is a strong and consistent predictor of death after hip fracture. 4, [7] [8] [9] [10] [11] [12] Also when taking into account the shorter life expectancy of men, 13 men have higher excess mortality after hip fracture. 3, 4, 14, 15 Comorbidity can be defined as the total burden of illness. Illnesses vary in their nature, extent, and severity. Comorbidity is associated with greater mortality in individuals with hip fracture, 5, 10, 16 but the contribution of preexisting illness to mortality after hip fracture is unresolved. In register data from Sweden, post-hip fracture mortality was largely related to comorbidity. 17 In contrast, a Danish study concluded that only a minor proportion of mortality could be attributed to preexisting comorbidity. 18 In a metaanalysis of 8 population-based European cohorts, the effect of hip fracture on mortality was only slightly attenuated when taking major chronic diseases into account. 15 Few studies have examined in detail the contribution of gender differences in comorbidity to differences in excess mortality after hip fracture, and the findings are ambiguous. In national register data from Denmark, gender differences in comorbidity did not affect differences in mortality. 5 We aimed to examine whether this was the case also in older adults in Norway, a population with many similarities, including long life expectancy and a high fracture incidence. The aim of this study was to explore whether comorbidity differs between men and women with hip fracture and to which degree differences according to gender in comorbidity may explain the greater excess mortality in men after hip fracture.
METHODS

Study Population and Demographic Data
We retrieved data from electronic administrative systems on all admissions for hip fracture to hospitals in Norway from the NORHip database established by the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS). 19 For the current study, we included all individuals aged 50 and older who had their first hip fracture from 2005 to 2008 (n = 32,175; Supplementary Figure S1 ). The source population for controls was identified in the Norwegian Population and Housing Census 2001 (Statistics Norway) and comprised Norwegian residents aged 50 and older by 2008 who had not had a hip fracture from 1994 to 2004 (n = 1,675,893). For each individual with hip fracture, we drew three controls, matched on birth year, gender, and county of residence and conditioned on being alive, residing in Norway, and being free of hip fracture on the fracture date of the patient. Only 61 individuals with hip fracture (0.2%) had fewer than three available controls, and 96,410 matched controls were included. Data on birth year, gender, county of residence, marital status, immigration status, number of children, and educational level were obtained from the Norwegian Population and Housing Census 2001. The National Registry provided dates of death or emigration.
Comorbidity
All concurrent diagnoses that the treating doctors deemed relevant during the hospitalization for hip fracture were available in NORHip, coded according to the International Classification of Diseases, Tenth Revision (ICD-10). These diagnoses enabled us to calculate individual Charlson Comorbidity Index (CCI) scores. 20, 21 The index has been shown to be prognostic of mortality in individuals with hip fracture. [22] [23] [24] It is based on information about whether a patient has any of the diagnoses on a list of given conditions, and each condition is weighted according to severity (Supplementary Table S1 ). We calculated individual CCI scores using a specially developed Stata syntax, 25 truncated to 0, 1, or 2 or more. As such, a score of 0 indicates that none of the listed conditions were registered during the individual's hospital stay, a score of 1 indicates having one condition of low severity, and a score of 2 or more reflects having 2 or more conditions of any severity or one or more conditions of high severity. Individual information about chronic diseases was not available in controls. The morbidity level of the controls reflects the distribution of morbidity in the general population of older adults without hip fracture.
Statistical Analysis
Data management and statistical analysis were performed using Stata 14. Age was included as a continuous variable. We estimated adjusted proportions of death in individuals with hip fracture according to CCI score and specific comorbid diagnoses using analysis of variance. We used Cox proportional hazards regression to estimate survival in CCI categories relative to non-hip fracture controls, separately for men and women. The individual's admission date was defined as entry date in the analysis for the patient and his or her matched controls, and end of follow-up was set to 365 days after fracture. To quantify the risk of death on an additive scale, we performed robust linear regression using the matched controls as the reference category. We thus estimated 1-year risk of death as the constant in linear regression for controls (reference), adjusted to mean age within each gender, and percentage points higher risk of dying in each CCI category as the beta coefficients in linear regression. We performed additional analyses stratified according to tertile of age. All regression models were adjusted for the matching variables (birth year, gender, county of residence). Proportions of deaths according to specific diagnoses were also adjusted for the individual's total number of comorbid diagnoses. Additional adjustment for marital status (married, widowed, other), immigrant status yes/no (foreign-born with 0 or 1 Norwegian-born parent or Norwegian-born with 2 foreign-born parents), educational level (completed first year of secondary school or higher (≥10 years) vs completed primary school or lower (≤9 years)), and having children (yes/no) in any of the above-mentioned analyses resulted in only negligible changes to the estimates, and we have not presented these results. The significance level was set to .05 in all analyses.
RESULTS
Participant Characteristics
Age at hip fracture ranged from 50 to 105, and women were on average 3 years older than men (Table 1) . A higher proportion of men were married, and more women were widowed. Men had more education. Men also had a significantly higher average number of diagnoses registered during the hospital stay, and a higher proportion of men had a CCI of 2 or greater. One in 5 women and 1 in 3 men died within 1 year after the fracture (Table 1) .
Comorbidity and Risk of Death in Individuals With Hip Fracture
Risk of dying within 1 year after hip fracture, adjusted for age and county of residence within the groups of men and women, was greater in individuals with higher CCI scores (Supplementary Table S2 ). An adjusted proportion of 11% of women with a CCI of 0, 24% of those with a CCI of 1, and 41% of those with a CCI of 2 or greater died within 1 year. The corresponding incidence proportions in men were 22%, 38%, and 52%.
A larger proportion of women (52%) than of men (45%) had no CCI diagnosis registered (Supplementary  Table S3 ). All comorbid diagnoses were more prevalent in men except rheumatic disease. In women, dementia was the most prevalent diagnosis (12%), whereas chronic lung disease and dementia were equally prevalent in men (14%). The adjusted proportion of deaths within 1 year in those with a dementia diagnosis was 36% of women and 57% of men. The proportion of deaths was higher in men for all registered CCI diagnoses (Supplementary Table S3 ).
Relative Risk of Death According to Gender and Comorbidity
There was a strong association between CCI score and 1-year mortality in both men and women with hip fracture when compared with controls (Table 2, Supplementary Figure S2 ). Patients with higher CCI scores had a higher relative risk than those with lower scores, but even patients without registered comorbidity (CCI 0) had a higher risk than controls ( Table 2 ). The interaction between age and comorbidity was statistically significant (P < .001 for both genders). Cox regression stratified according to tertile of age distribution (50-79, 80-86, 87-105) revealed that the relative excess mortality due to comorbidity was greatest at younger ages in both genders (Supplementary Table S4 ).
Adjusted for age, men with hip fracture had a twofold risk of dying within 1 year compared with women with hip fracture (HR = 2.0, 95% CI = 1.9-2.1). Adjustment for comorbidity reduced this difference slightly (HR = 1.8, 95% CI = 1.7-1.8). The relative difference between men and women was lower at higher CCI scores (HR = 2.3, 95% CI = 2.1-2.5 for CCI of 0; HR = 1.9, 95% CI = 1.7-2.0 for CCI of 1; HR = 1.4, 95% CI = 1.3-1.5 for CCI of ≥2). In the control group, men had HR = 1.4 (95% CI = 1.3-1.5) compared with women for dying within 1 year.
Risk Difference in Death According to Gender and Comorbidity
In linear regression, estimated risk of death within 1 year in the matched nonfracture controls was 11% in women and 12% in men, adjusted for age and county of residence within genders (Table 3 ). There was increasing 1-year risk of death with increasing CCI level. The large difference between individuals with hip fracture and controls contributed most to the gender difference in excess risk of death after hip fracture, whereas the gender difference in added risk of death by greater CCI in individuals with hip fracture was small. The estimated risk difference between patients with a CCI of 2 or greater and those with with a CCI of 0 was 29 percentage points in both genders (Table 3) .
DISCUSSION
This population-wide study of all individuals hospitalized with a first hip fracture in Norway over a 4-year period showed that men who had a hip fracture had greater comorbidity than women. A higher comorbidity burden was associated with greater excess 1-year mortality in both genders, and the association was even stronger in men, but the gender difference in comorbidity did not explain the gender difference in 1-year mortality.
It has been reported in many studies that excess mortality after hip fracture is higher in men, [3] [4] [5] 8, 9, 11, 12 despite men being younger when experiencing a hip fracture. It has been proposed that higher prevalence and severity of preexisting chronic diseases in men who have a hip fracture contribute to their poorer prognosis. Comorbidity is a recognized predictor of mortality after hip fracture, 5, 10, 16 but its contribution is unresolved. In register data from Sweden, it was estimated that the majority of deaths after hip fracture were due to preexisting illnesses. 17 In contrast, a patient register study in Denmark found that the excess mortality after hip fracture was only slightly attenuated (from HR = 2.26 to HR = 1.95) when taking into account CCI score. The authors concluded that the greater mortality appeared to be largely related to the fracture event itself. 18 In our data, men had a twofold risk of dying within 1 year compared with women. The difference in mortality according to gender was only slightly attenuated by taking into account comorbidity level, and it remained higher than in the background population. This is in line with the finding of an age-adjusted 70% greater post-hip fracture mortality in men than women in Denmark, which adjustment for comorbidity did not affect. 5 These results suggest that other gender-related differences not accounted for by comorbid diagnoses contribute to the greater excess mortality in men after hip fracture. A recent study found no differences according to gender in quality of in-hospital care for hip fracture, defined according to several process performance measures. 12 Use of bisphosphonates may reduce mortality. 26 The prevalence of use of these drugs after hip fracture is low, especially in men. 27 The statistical interaction between age and comorbidity revealed a greater relative effect of increasing comorbidity on excess mortality in younger individuals with hip fracture. In general, the excess mortality after hip fracture expressed as standardized mortality rates is higher at younger ages because of the lower background mortality. 4 A strength of our study is that it is based on a nationwide database of hip fracture admissions to all hospitals in Norway linked with national register data covering the whole population. All individuals treated for hip fracture were included regardless of geographic area and socioeconomic position. We had data on all deaths and almost complete demographic data for individuals with hip fracture and matched controls. Statistical power was high, giving precise results. A limitation was the lack of data on chronic diseases in the background population. Controls were a random sample with the same age, gender, and geographic distribution as individuals with hip fracture, reflecting the distribution of morbidity in the general population of older adults. In that respect, the clearly greater mortality in hip fracture patients with no registered comorbidity is remarkable.
The measure of comorbidity in the individuals with hip fracture is not ideal in terms of sensitivity nor in specificity. The ICD-10 diagnoses codes used to define comorbidity were recorded during the hospital stay when the hip fracture was treated and are expected to be an underestimation of the true prevalence of comorbidity. Hospital routines require that diagnoses deemed relevant for the stay be recorded, but hospitals' financing systems may influence coding practices. Therefore, we do not expect to have captured the true level of comorbidity, which is a general problem when using comorbidity scores from administrative patient data, 28 although for the current purpose, we do not expect that underestimation of comorbidity should differ systematically according to gender.
Our study shows that comorbidity places people at particular risk of death after hip fracture. This information should be used in the management of individuals with hip fracture to direct attention to comorbidities so that, with targeted care, an individual's risk of death may be lowered. Many comorbidities are also associated with greater risk of fracturing a hip in the first place. 29, 30 As such, knowledge about comorbid conditions is important not just in inpatient management, but also for prevention purposes. Regarding prognosis, men who fracture a hip are especially vulnerable, even when there is no apparent comorbidity, and they may warrant special attention in follow-up. Although age-specific incidence rates of hip fracture have declined in recent decades, 2 this decline has been lower in men than women, and the future fracture burden is expected to increase due to an aging population that continues to grow. Thus, there is a great need for improvement in prevention of fracture and in reducing postfracture mortality in women and men.
CONCLUSION
Our study covering the population aged 50 and older in Norway showed that men who had a hip fracture had a higher comorbidity burden than women. Higher comorbidity scores were associated with greater excess 1-year mortality in both genders, with the association stronger in men, but the difference in comorbidity did not explain the gender difference in 1-year mortality. Factors not accounted for by comorbid diagnoses, such as factors related to the fracture event itself or other aspects of the follow-up and care of men with hip fracture might partially explain the greater excess mortality in men. Awareness is needed of risk factors such as poor Author Contributions: BSLR reviewed the literature, performed the data analyses, and drafted the manuscript in collaboration with KH. LF advised on statistical methods. TKO, AJS, and HEM critically revised the manuscript for intellectual content. All authors read and approved the final manuscript.
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